A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults with COVID-19 (ACTIV-4A)

Open For Enrollment

Please contact us for more information or to learn if you are eligible to participate.

The objective of this study is to learn which treatment strategies are best for reducing the primary, secondary, and safety outcomes.

Principal Investigator	Marcel B. Twahirwa, MD
Sponsor	NHLBI, NINDS, ACTIV IV, NIH, BARDA, OWS, HHS
Type of Trial	Interventional

5323 S. McColl Rd., Edinburg, TX 78539

(956) 362-2390